Related Experiment Video
Updated: Dec 7, 2025

09:36
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
Published on: June 28, 2019
10.4K
Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
Pauline Mencke1, Zoé Hanss1, Ibrahim Boussaad1
1Translational Neuroscience, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg, Luxembourg.
Frontiers in Neurology
|September 25, 2020
Summary
Parkinson's disease (PD) and cancer exhibit inverse gene regulation, with shared genes showing opposite expression patterns. Studying these common pathways in PD and glioblastoma multiforme (GBM) may reveal new therapeutic targets.
Area of Science:
- Neuroscience
- Oncology
- Genetics
Background:
- Parkinson's disease (PD) and cancer involve opposing cellular mechanisms: PD relates to cell death, while cancer involves uncontrolled cell proliferation.
- Epidemiological studies suggest an inverse relationship between PD and cancer incidence.
- Certain genes, like p53 and PARK7, are oppositely regulated in PD and cancer tissues.
Purpose of the Study:
- To explore the involvement of PD- and glioblastoma multiforme (GBM)-associated genes in common dysregulated pathways.
- To understand the mechanistic basis of PD and GBM by examining inverse gene regulation.
- To identify novel therapeutic strategies for PD and GBM.
Main Methods:
- Comparative analysis of gene expression patterns in PD and GBM.
- Review of existing epidemiological and genetic studies.
- Pathway analysis of common genes involved in both diseases.
Main Results:
- Genes involved in PD and GBM are often oppositely regulated, with down-regulation in one disease corresponding to up-regulation in the other.
- Common pathways related to cell proliferation and metabolism are dysregulated in opposite directions in PD and GBM.
- Astrocytes show opposing dysregulation in both PD and GBM.
Conclusions:
- Simultaneous study of PD and GBM offers insights into their underlying mechanisms.
- Understanding inverse gene regulation in PD and GBM can lead to novel, targeted treatment strategies.
- Further research into shared pathways may unlock new therapeutic avenues for these incurable conditions.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Parkinson's Disease: Treatment
808
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
808
Neural Regulation
42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K

